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Identification and Molecular Characterization
of Fractalkine Receptor CX3CR1, which
Mediates Both Leukocyte Migration and Adhesion
Chemokines are a group of small, structurally related,
and frequently heparin-binding cytokines that provide
important signals for leukocyte migration through induc-
tion of cell motility and activation of adhesion molecules
(Baggiolini et al., 1994; Schall and Bacon, 1994; Rollins,
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1997). Chemokines are divided into three major subfami-Settsu 566
lies, CXC, CC, and C, based on the number and spacingJapan
of the first two cysteines in a conserved cysteine struc-²Department of Biochemistry
tural motif. Different chemokine classes tend to exhibitKumamoto University Medical School
different ranges of leukocyte specificity: the CXC mole-Kumamoto 860
cules seem biased in targeting neutrophils and to aJapan
lesser extent lymphocytes; the CC molecules mainly³Department of Immunology
target monocytes, and also lymphocytes, basophils, andDNAX Research Institute
eosinophils, with varying selectivity; and the C chemo-Palo Alto, California 94304
kine appears to act preferentially on lymphocytes (Bag-
giolini et al., 1994; Schall and Bacon, 1994; Rollins,
1997). Chemokine receptors identified to date on leuko-Summary
cytes all manifest a seven transmembrane (7-TM) G pro-
tein±linked architecture (Murphy, 1994; Premack andLeukocyte trafficking at the endothelium requires both
Schall, 1996). It is known that they transduce signalscellular adhesion molecules and chemotactic factors.
that lead to cytoskeletal reorganization, integrin activa-Fractalkine, a novel transmembrane molecule with a
tion, and other functions leading to increased adhesionCX3C-motif chemokine domain atop a mucin stalk, in-
and migration of the cells. These effects are frequentlyduces both adhesion and migration of leukocytes.
mediated through pertussis toxin (PT)±sensitive G pro-Here we identify a seven-transmembrane high-affinity
tein±coupled pathways.receptor for fractalkine and show that it mediates both
Recently, a novel fourth class of chemokine, fractal-the adhesive and migratory functions of fractalkine.
kine, has been identified and characterized (Bazan etThe receptor, now termed CX3CR1, requires pertussis
al., 1997). Fractalkine is structurally distinct from othertoxin±sensitive G protein signaling to induce migration
types of chemokines. This molecule contains a uniquebut not to support adhesion, which also occurs without
CX3C motif and exists as a membrane-bound gly-other adhesion molecules but requires the architec-
coprotein with the chemokine domain atop an extendedture of a chemokine domain atop the mucin stalk.
mucin-like stalk. Membrane-bound fractalkine can beNatural killer cells predominantly express CX3CR1 and markedly induced on primary endothelial cells by inflam-respond to fractalkine in both migration and adhesion.
matory cytokines; this form promotes the robust adhe-Thus, fractalkine and CX3CR1 represent new types of sion of monocytes and T lymphocytes. Soluble fractal-leukocyte trafficking regulators, performing both ad-
kine can be released, presumably by proteolysis at ahesive and chemotactic functions.
membrane-proximal dibasic cleavage site similar to
those of syndecans, and exhibits an efficient chemotac-
Introduction
tic activity for monocytes and T cells. Thus, fractalkine
is a versatile molecule regulating both cell±cell interac-
Blood leukocytes rapidly emigrate into sites of injury or tions as the membrane-bound form and directed cell
infection, while mature lymphocytes continually recircu-
migration by its soluble form.
late between blood and tissues. These migratory proper-
The novel structure and functions of fractalkine sug-
ties of blood leukocytes and circulating lymphocytes
gest that it may play a key role in the multistep process
are essential for host defense and immunological sur- of leukocyte trafficking, while raising several issues. It
veillance. The molecular control of these essential traf- is not known whether fractalkine induces both its migra-
ficking events requires two broad classes of molecules: tory and adhesive effects directly and whether it func-
various cell adhesion molecules, especially those of se- tions through a standard 7-TM chemokine receptor, an
lectins and integrins, as well as leukocyte chemotactic adhesion counter receptor, or a combination of both.
factors including the members of the chemokine super- We set out to address these questions first by identifying
family (Butcher, 1991; Springer, 1994; Butcher and Picker, the fractalkine receptor and then to use this information
1996). Chemokines have been postulated to work in con- to dissect the molecular functions of the receptor-ligand
cert with adhesion molecules in selective trafficking of pair. We report here the identification of a high-affinity
specific leukocyte classes and lymphocyte subsets, yet functional receptor for fractalkine, CX3CR1, and how
many of the molecular workings of these processes re- fractalkine and CX3CR1 directly mediate the adhesion
main to be elucidated. and migration of leukocytes such as monocytes and NK
cells. Our findings suggest that fractalkine and CX3CR1
represent a new class of leukocyte trafficking regulator,§Present Address: Molecular Medicine Research Institute, 325 E.
where the hybrid functions of both adhesion and migra-Middlefield Road, Mt. View, California 94043.
‖ To whom correspondence should be addressed. tion are combined at molecular and functional levels.
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Figure 2. V28 Is a Specific, High-Affinity Receptor for Fractalkine
(A) Specific binding of soluble Fractalkine-SEAP to V28-transfected
K562 cells. Cells (2 3 105 cells) were incubated for 1 hr at 168C with
1 nM of Fractalkine-SEAP. After washing, bound Fractalkine-SEAP
Figure 1. High-Affinity Binding of SolubleFractalkine-SEAP to Fresh was determined enzymatically (Imai et al., 1997). Each histogram
Peripheral Blood Lymphocytes and Monocytes represents mean 6 range.
(A) Purified Fractalkine-SEAP fusion protein. Fractalkine-SEAP was (B) Saturable binding of Fractalkine-SEAP to V28-transfected K562
purified from culture supernatants of transfected 293/EBNA-1 cells cells. Cells (2 3 105 cells) were incubated for 1 hr at 168C with
by a metal affinity chromatography. After electrophoresis on a 4%± indicated concentrations of Fractalkine-SEAP. Nonspecific binding
20% gradient polyacrylamide gel, proteins were stained with Coo- was determined by the addition of 200 nM of soluble fractalkine and
massie brilliant blue. Positions of size markers (kDa) are shown on subtracted. Representative results from three separate experiments
the right. are shown. Insert shows Scatchard analysis of the binding data.
(B and C) Saturable binding of Fractalkine-SEAP to lymphocytes The calculated Kd is 100 pM.
and monocytes. Cells (2 3 105 cells) were incubated for 1 hr at 168C (C) Induction of chemotaxis in V28-transfected cells by soluble frac-
with indicated concentrations of Fractalkine-SEAP. Nonspecific talkine. 293/EBNA-1 cells transfected with V28 (closed circles) or
binding was determined by the addition of 200 nM of soluble fractal- vector alone (open triangles) were tested for migration toward solu-
kine and subtracted. Representative results from three separate ble fractalkine at indicated concentrations by using a 48-well che-
experiments are shown. Inserts show Scatchard analysis of the motaxis chamber. The assay was done in triplicate, and the number
binding data. The calculated Kds are 30 pM for lymphocytes and 50 of migrating cells in five high-power fields (4003) were counted for
pM for monocytes. each well. Representative results from three separate experiments
are shown. Each point represents mean 6 SEM.
(D) Calcium mobilization in V28-transfected K562 cells by soluble
fractalkine. Cells with or without pretreatment with PT (PT) at 500Results
ng/ml for 1 hr were loaded with fura-PE3-AM and stimulated with
soluble fractalkine (100nM). Arrowheads indicate time of application
Use of Fractalkine-Alkaline Phosphatase Fusion of soluble fractalkine. Intracellular concentration of calcium was
Protein for Receptor Detection monitored by fluorescence ratio (F340/F380). Representative results
from three separate experiments are shown.Previous studies have shown that chemokines fused
with thesecreted form of placental alkaline phosphatase
(SEAP) retain their ability to bind specifically to their cell-
surface receptors, while the phosphatase activity allows that lymphocytes and monocytes express a single class
of high-affinity receptors for fractalkine.quantitative determination of specific binding (Luster et
al., 1995; Imai et al., 1997). To prepare labeled fractalkine
for receptor binding experiments, we expressed soluble V28 Is a High-Affinity Functional Receptor
for Fractalkinefractalkine fused with SEAP (Fractalkine-SEAP). As
shown in Figure 1A, purified Fractalkine-SEAP exhibited To identify the fractalkine receptor, we tested the bind-
ing of Fractalkine-SEAP to the seven known CC chemo-a broad band with an apparent molecular mass of 150
kDa, consistent with the observed Mr of the soluble form kine receptors (CCR1±CCR7) (Baba et al., 1997; Imai et
al., 1997; Rollins, 1997; Yoshida et al., 1997) and several(Bazan et al., 1997) with the added mass of SEAP and
(His)6. To characterize fractalkine receptor, we first car- ªorphanº receptors: BLR1 (Dobner et al., 1992), V28
(Combadiere et al., 1995; Raport et al., 1995), and GPR-ried out Fractalkine-SEAP binding experiments using
peripheral blood lymphocytes and monocytes known to 9±6 (GenBank accession number: HSU45982). Of the
receptors tested, Fractalkine-SEAP bound specificallyrespond to fractalkine (Bazan et al., 1997). When the
binding was performed with increasing concentrations to V28 expressed on K562 (Figure 2A) as well as on Raji
and 293/EBNA-1 (data not shown). When the bindingof Fractalkine-SEAP, a single class of receptors was
revealed on lymphocytes with a Kd of 30 pM and 440 was performed with increasing concentrations of Frac-
talkine-SEAP, K562-V28 demonstrated a single class ofsites per cell (Figure 1B) and on monocytes with a Kd
of 50 pM and 450 sites per cell (Figure 1C). These results receptors for Fractalkine-SEAP with a Kd of 100 pM and
20,000 sites per cell (Figure 2B). This high-affinity bind-clearly demonstrated that Fractalkine-SEAP functions
as a high-affinity ligand for the fractalkine receptor, and ing of Fractalkine-SEAP to V28 was quite consistent
Identification of Fractalkine Receptor CX3CR1
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Figure 3. Role of Signaling via V28 in Adhe-
sion to Fractalkine
(A) Specific adhesion to immobilized Fractal-
kine-SEAP. Cells transfected with vector alone
or V28 were applied to wells precoated with
SEAP or Fractalkine-SEAP (4000 cells/mm2)
and incubated for 30 min at room tempera-
ture. After washing off nonadherent cells by
dipping the slides gently in assay buffer twice,
adherent cells were fixed with 1% glutaralde-
hyde and counted in five 4003 fields (0.07
mm2) per well. The data shown represent
mean 6 SEM from at least three independent
experiments. Closed columns, K562; shaded
columns, 293/EBNA-1; open columns, Raji.
(B) Calcium mobilization in V28-transfected
cells by soluble fractalkine. Cells were loaded
with fura-PE3-AM and stimulated with solu-
ble fractalkine (10 nM). Arrowheads indicate
time of application of soluble fractalkine.
Intracellular concentration of calcium was
monitored by fluorescence ratio (F340/F380).
Representative results from three separate
experiments are shown.
(C) Effect of various treatments on binding of V28-transfected K562 to immobilized Fractalkine-SEAP. For 48C treatment, adhesion assay was
performed at 48C for 30 min. For soluble fractalkine (sFk) or EDTA/EGTA treatments, 10 mg/ml of soluble fractalkine or 5 mM of EDTA/EGTA
was added to the assay buffer during the assay. For treatment with PT, cells were pretreated with PT at 500 ng/ml for 30 min at 378C and
washed before the assay. The data shown represent mean 6 SEM of percent adhesion of control (without inhibitor or treatment) from at least
three separate experiments.
(D) Effect of PT treatment on fractalkine-mediated adhesion, chemotaxis, and calcium mobilization of V28-transfected 293/EBNA-1. Cells
without (closed columns) or with pretreatment with PT at 500 ng/ml for 30 min at 378C (shaded columns) were assessed for calcium mobilization
stimulated with soluble fractalkine (10 nM), chemotaxis response induced by soluble fractalkine (10 nM), and cell adhesion to immobilized
Fractalkine-SEAP. The data shown represent mean 6 SEM of percent response of control (without PT) from two separate experiments.
with those obtained with the endogenous fractalkine in Figure 3A, K562, 293/EBNA-1, and Raji transfected
with V28 efficiently adhered to immobilized Fractalkine-receptors expressed on lymphocytes and monocytes
(Figure 1). SEAP, but not to SEAP alone. The cells transfected with
the vector alone did not adhere to immobilized Fractal-We next tested whether V28 was a functional receptor
for fractalkine. As shown inFigure 2C, soluble fractalkine kine-SEAP or SEAP at all. Adhesion of V28-transfected
cells to immobilized Fractalkine-SEAP appeared to beinduced a vigorous migration of V28-transfected 293/
EBNA-1 cells with a typical bell-shaped dose-response quite rapid, since most cells were already bound during
a few min at room temperature while they were allowedcurve and a maximum effect at 1 nM. 293/EBNA-1 cells
transfected with the vector alone did not respond to to settle down at 13 g. The adhesion was also quite
stable even when cells were incubated at 378C for 1 hr.fractalkine at all. A checkerboard-type analysis indi-
cated that the migration of V28-transfected 293/EBNA-1 This contrasted to the previous observation that adhe-
sion of T cells and monocytes to fractalkine-expressingcells toward soluble fractalkine was mostly chemotactic
(data not shown). As shown in Figure 2D, fractalkine also HEK 293 cells was transient (Bazan et al., 1997). This
may suggest adhesion-regulatory activity bythese typesinduced a vigorous calcium flux in K562 cells expressing
V28 with complete desensitization to successive stimu- of cells, such as cleavage of cell surface fractalkine
sometime after cell±cell binding. Another notable pointlation with fractalkine. No such response to fractalkine
was seen in parental K562 cellsor those transfected with was that, in contrast to V28-transfected K562 and 293/
EBNA-1 cells, V28-transfected Raji cells did not respondthe vector alone (data not shown). Fractalkine-induced
calcium mobilization in K562-V28 cells was detectable to soluble fractalkine in the calcium mobilization assay
at all (Figure 3B). We confirmed that the levels of V28at 0.1 nM and reached a maximum level at 10 nM with
an EC50 of 2 nM (data not shown). Furthermore, pretreat- expression on the cell surface of K562, 293/EBNA-1,
and Raji as determined by the Fractalkine-SEAP bindingment of K562-V28 cells with PT completely abolished
this calcium mobilization (Figure 2D), indicating signal assay (see below) were quite similar (data not shown).
This implied that calcium mobilization might not be re-transduction through Gai-class Gproteins. These obser-
vations clearly demonstrated that V28 was indeed a quired for V28-mediated adhesion by fractalkine.
We further investigated the role of signaling via V28functional receptor for fractalkine.
in fractalkine-induced adhesion. As shown in Figure 3C,
soluble fractalkine (SFK) was found to suppress com-V28 Mediates Cell Adhesion
We next examined whether fractalkine supports adhe- pletely the adhesion of K562-V28 to immobilized Fractal-
kine-SEAP. This was striking because soluble fractal-sion of V28-expressing cells. To minimize involvement
of other cell adhesion molecules acting in parallel or in kine itself was a potent agonist for V28 in chemotaxis
and calcium mobilization (Figure 2). The adhesion wastrans, we used glass slides on which Fractalkine-SEAP
was immobilized through anti-SEAP antibody. As shown also almost completely suppressed at 48C. On the other
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hand, adhesion of K562-V28 to Fractalkine-SEAP was
not affected at all by depletion of divalent cations with
EDTA/EGTA. The same treatment was separately con-
firmed to suppress completely the integrin-mediated
cell aggregation of peripheral blood mononuclear cells
induced by phorbol myristate acetate (data not shown).
Furthermore, PT did not strongly affect the ability of
K562-V28 to adhere to immobilized Fractalkine-SEAP,
even thoughthe same treatment completely suppressed
calcium mobilization in K562-V28 by soluble fractalkine
(Figure 2B). We also confirmed that cholera toxin, which
is known to inhibit the Gs class of G proteins, did not
affect the adhesion either (data not shown). The effect
of PT was further examined by using 293/EBNA-1 cells.
As shown in Figure 3D, PT had no inhibitory effect on
adhesion of V28-expressing 293/EBNA-1 to immobilized
Fractalkine-SEAP while it completely inhibited calcium
flux and chemotaxis in the same cells induced by soluble
fractalkine. Collectively, immobilized Fractalkine-SEAP
appeared to induce stable adhesion of V28-expressing
cells without involving additional adhesion molecules
such as integrins or selectins and without signaling
through PT-sensitive G proteins. The temperature de-
pendence of adhesion might indicate involvement of
other signaling pathways or necessity of membrane flu-
idity to allow multiple associations.
Roles of the Chemokine and Mucin
Domains in Adhesion
To define the respective roles of the chemokine and
mucin domains of fractalkine in adhesion, we next gen-
erated three representative mutants: (1) Mucin-SEAP
lacking the CX3C-chemokine domain; (2) CX3C-SEAP
lacking the mucin domain; and (3) TARC-Mucin-SEAP,
a chimera where the CX3C domain was replaced by a
CC chemokine TARC (Imai et al., 1997). We first deter-
mined the domain responsible for V28 binding. As shown
Figure 4. Role of the Chemokine and Mucin Domains in Adhesion
in Figure 4A, CX3C-SEAP bound to V28-expressing K562 (A) The role of chemokine and mucin domains in binding to V28.
cells as efficiently as Fractalkine-SEAP. Their binding V28-transfected K562 cells were incubated for 1 hr at 168C with
affinity and number of binding sites were equivalent. In indicated concentrations of the SEAP fusion proteins. Nonspecific
contrast, Mucin-SEAP did not bind to V28 at all. These binding was determined by addition of 200 nM of soluble fractalkine
and subtracted. Representative results from three separate experi-results clearly indicated that the CX3C domain was solely
ments are shown.responsible for binding to V28 while the mucin domain
(B and C) The role of chemokine and mucin domains in adhesionhad no direct role. We next examined the role of each
to various immobilized SEAP fusion proteins. The percent adhesionfractalkine domain in adhesion of V28-expressing cells.
of input cells was determined by counting cells in five 4003 fields
As shown in Figure 4B, immobilized Fractalkine-SEAP (0.07 mm2) per well. The data shown represent mean 6 SEM of
(Fk-SEAP), but not those lacking the CX3C domain (i.e., percentadhesion of input cells from at least two independent experi-
SEAP, TARC-Mucin-SEAP and Mucin-SEAP), supported ments.
(D) Inhibitory effect of indicated soluble SEAP fusion proteins onadhesion of V28-expressing K562. This confirmed that
adhesion of V28-transfected K562 cells to immobilized Fractalkine-the CX3C domain was essential for interaction with V28.
SEAP. The percent adhesion of input cells was determined by count-Notably, immobilized CX3C-SEAP lacking the mucin do-
ing cells in five 4003 fields (0.07 mm2) per well.main failed to support the adhesion of K562-V28 cells,
even though soluble CX3C-SEAP bound to V28 as effi-
Mucin-SEAP. Furthermore, TARC, but not soluble frac-ciently as soluble Fractalkine-SEAP (Figure 4A). Thus,
talkine, inhibited K562-CCR4 adhesion to immobilizedthe mucin domain appeared to be somehow involved
TARC-Mucin-SEAP. Another important point was thatin the adhesion process. The combination of the two
K562-CCR4 cells again failed to adhere efficiently tomutants (CX3C-SEAP 1 Mucin-SEAP), however, failed
immobilized TARC-SEAP lacking the mucin domain.to support the adhesion in trans. Unexpectedly, when
To further test the respective roles of the chemokinewe carried out the same experiments using CCR4-
and mucin domains in adhesion, we assessed inhibitoryexpressing K562 cells (Figure 4C), these cells were
activity of various soluble SEAP fusion proteinson adhe-found to adhere efficiently to immobilized TARC-Mucin-
sion of K562-V28 cells to immobilized Fractalkine-SEAP.SEAP. This adhesion was mediated by the specific inter-
In these experiments, Fractalkine-SEAP was directly im-action of CCR4 and TARC (Imai et al., 1997), since K562-
CCR4 did not adhere to SEAP, Fractalkine-SEAP, or mobilized onto glass slides. As shown in Figure 4D,
Identification of Fractalkine Receptor CX3CR1
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not be directly involved in adhesion; the data strongly
suggest that the chemokine domain and V28 were solely
responsible for direct receptor engagement and ad-
hesion.
Expression of V28 and Fractalkine Receptor
in Leukocyte Classes and Subsets
We next proceeded to determine the expression of V28
mRNA and surface fractalkine receptor in various types
of leukocytes. As shown in Figure 5A, among freshly
isolated normal peripheral blood leukocytes, V28 mRNA
was expressed mainly in CD161 natural killer (NK) cells.
After long exposure, low levels of the mRNA were de-
tected in CD31 T cells, CD141 monocytes (Mo), and
granulocytes (Gr), while CD191 B cells were virtually
negative. Expression of V28 mRNA in both CD41 and
CD81 T cells was strongly up-regulated by IL-2 (Figure
5A). The effect of IL-2 was, however, completely sup-
pressed by cotreatment with phytohemagglutinin (PHA).
Thus, the expression of V28 in T cells is positively regu-
lated by IL-2 butnegatively regulated by T-cell activation
like those of CCR1 and CCR2 (Loetscher et al., 1996).
To assess surface expression of fractalkine receptor on
various leukocyte subsets, cells were incubated with
Fractalkine-SEAP and then reacted with biotinylated
anti-SEAP antibody. Subsequently, cells were double-
stained with FITC-labeled streptavidin and with PE-
labeled antibody for indicated surface makers (Figure
5B). As summarized in Figure 5C, most CD161 NK cells
(z92%) werepositive for fractalkine receptor. A subpop-
ulation of CD31 T cells (z14%) also expressed fractal-
kine receptor. The CD31 T cells that expressed fractalkine
receptor were mostly CD81 T cells, although some indi-
viduals contained both CD41 and CD81 T cells express-
ing fractalkine receptor at similar levels as shown in
Figure 5B. Very few CD191 B cells expressed fractalkine
receptor. The surface expression pattern of the fractal-
kine receptor on lymphocytes thus correlates well withFigure 5. Expression of V28 mRNA and Surface Fractalkine Recep-
the pattern of V28 mRNA expression (Figure 5A). Thetor in Human Peripheral Blood Leukocyte Populations
majority of CD141 monocytes (79%) also expressed(A) Expression of V28 mRNA. Total RNA samples (5 mg per lane)
were subjected to Northern blot analysis by using the 32P-labeled fractalkine receptor. On the other hand, virtually no frac-
V28 cDNA as probe. The autoradiograph of the filter (upper) and talkine receptor was detected on the surface of granulo-
the photograph of the gel stained with ethidium bromide (lower) are cytes, although V28 mRNA was present at low levels in
shown. Positions of size markers (kb) are shown on the left. Left
these cells (Figure 5A).panel: T4, CD41 T cells; T8, CD81 T cells; T, total T cells; B, B cells;
NK, natural killer cells; Mo, monocytes; and Gr, granulocytes. Right
panel: fresh CD41 T cells (T4), CD81 T cells (T8); and those cultured Transendothelial Chemotactic Activity
in the presence of IL-2 (400 U/ml) without or with PHA for 5 days. of Fractalkine(B) Surface expression of fractalkine receptor. PBMC were incu-
After demonstrating the expression of V28 mRNA andbated with SEAP or Fractalkine-SEAP at 48C for 30 min. After wash-
surface fractalkine receptor in particular subsets of leu-ing, cells were incubated with biotinylated anti-SEAP antibody at
48C for 30 min. After washing, cells were stained with FITC-streptavi- kocytes, we examined the phenotypes of cells migrating
din and PE-labeled antibody for indicated cell surface makers. After toward fractalkine by using the transendothelial migra-
washing, cells were analyzed on a FACStar Plus gating for lympho- tion assay (Carr et al., 1994; Oin et al., 1996). Soluble
cytes. For CD141 monocytes, a scatter-gated population was used
fractalkine induced migration of both lymphocytes andfor analysis. Representative results are shown.
monocytes through endothelial cells with a maximum(C) The mean 6 SEM from three different donors.
response at 10 nM (Figure 6A). The efficacy of fractalkine
was comparable to that of MCP-1 in lymphocyte chemo-
taxis (see below). The efficacy of fractalkine was, how-not only soluble Fractalkine-SEAP but also CX3C-SEAP
without the mucin domain strongly suppressed the ad- ever, much lower than MCP-1 in monocyte chemotaxis
(1.5% versus 30.7%). Among the lymphocyte subpopu-hesion of K562-V28 to immobilized Fractalkine-SEAP.
On the other hand, Mucin-SEAP or TARC-Mucin-SEAP, lations, soluble fractalkine induced efficient migration
in CD161 NK cells and, to a lesser extent, in CD31CD81both having the mucin domain, had virtually no inhibitory
effect on the adhesion. Thus, the mucin domain might T cells (Figure 6B). CD31CD41 T cells also migrated to
Cell
526
Figure 7. Adhesion of V28-Transfected K562 Cells and Normal NKFigure 6. Transendothelial Migration of Human Leukocytes to Solu-
Cells to Fractalkine-Expressing Endothelial Cellsble Fractalkine
Control and fractalkine cDNA-transfected ECV304 cells were cul-(A) Classes of leukocytes migrating to soluble fractalkine. Cells mi-
tured overnight in 16-well glass slides precoated with polyethylene-grating from upper wells to lower wells wereenumerated by counting
imine (A and C). HUVEC were cultured in 16-well glass slides pre-for 30 sec on a FACStar Plus gating for lymphocytes or monocytes.
coated with fibronectin and activated with TNFa (50 ng/nl) for 10 hrThe data shown represent mean 6 range. Representative results
(B and C). After the cells in each well were gently washed, K562-from three different donors are shown.
V28 (A and B) or normal NK cells (C) were applied to wells and(B) Subsets of lymphocytes migrating to soluble fractalkine. Cells
incubated for 20 min at room temperature. After washing off nonad-migrated to soluble fractalkine were collected, stained with FITC-
herent cells by dipping the slides gently in assaybuffer twice, adher-conjugated or PE-conjugated antibodies for indicated surface mak-
ent cells were fixed with 1% glutaraldehyde. For treatment withers, and subjected to flow cytometric analysis. Representative re-
soluble fractalkine or EGTA/EDTA (EG/ED), 10 mg/ml of soluble frac-sults from three different donors are shown.
talkine or 5 mM of EGTA/EDTA was added during the assay. For(C) Subsets of lymphocytes migrating to soluble fractalkine, TARC,
treatment with PT, cells were pretreated with PT at 500 ng/ml for 1and MCP-1. Cells that migrated to medium (open columns), 10 nM
hr at 378C. Adhered cells were counted in five 4003 fields (0.07of soluble fractalkine (closed columns), 10 nM of TARC (shaded
mm2) per well. The data shown represent mean 6 SEM. Representa-columns), and 10 nM of MCP-1 (hatched columns) were collected,
tive results from at least two independent experiments are shown.stained with FITC-conjugated or PE-conjugated antibodies for indi-
cated surface makers, and subjected to flow cytometric analysis.
Representative results from three different donors are shown.
the subsets of leukocytes expressing V28 mRNA and
fractalkine receptor on the surface.
soluble fractalkine in some individuals at a very low effi-
ciency (,0.6%). Both CD45RO1 memory and CD45RO2
naive cells migrated toward soluble fractalkine (data not Adhesion of V28-Expressing Cells
to Membrane-Bound Fractalkineshown). No CD191 B cellsmigrated tosoluble fractalkine
at all. We further compared soluble fractalkine with TARC on Endothelium
We assessed the role of membrane-bound fractalkineand MCP-1 in the transendothelial migration assay (Fig-
ure 6C). CD31CD81 T cells were preferentially attracted in the adhesion of V28-expressing cells to endothelial
cells. As shown in Figure 7A, K562-V28 adhered toby soluble fractalkine, whereas CD31CD41 T cells were
preferentially attracted by TARC. Both CD31CD41 and ECV304 expressing the membrane form of fractalkine
6-fold more than to control ECV304 cells. Also, consis-CD31CD81 T cells were equally attracted by MCP-1.
However, only soluble fractalkine induced strong migra- tent with the results of adhesion of K562-V28 to immobi-
lized Fractalkine-SEAP (Figures 3 and 4), soluble fractal-tion in CD161 NK cells. Collectively, the phenotypes of
cells migrating to soluble fractalkine correlated well to kine almost completely suppressed the adhesion, while
Identification of Fractalkine Receptor CX3CR1
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PT 1 EDTA/EGTA had little inhibitory effect on the adhe- The previous study demonstrated the ability of fractal-
kine to support the adhesion of monocytes and T cellssion. Similar results were obtained when we examined
the adhesion of K562-V28 to primary HUVEC. As shown when expressed on HEK 293 cells (Bazan et al., 1997).
However, that report didnot address whether fractalkinein Figure 7B, K562-V28 cells showed 15-fold more ad-
herence to TNFa-stimulated HUVEC expressing endog- itself was an adhesion molecule or whether it was merely
inducing and/or activating other adhesion molecules onenous fractalkine (Bazan et al., 1997) than to control
HUVEC. Again, the adhesion of K562-V28 to activated the surface of HEK 293 cells, or leukocytes, or both. The
involvement of other adhesion molecules was an espe-HUVEC was strongly inhibited by soluble fractalkine but
only marginally affected by PT. Finally, we examined cially compelling notion since the mucin domain of frac-
talkine is reminiscent of structuresseen elsewhere in theadhesion of freshly isolated NK cells expressing endog-
enous V28 to ECV304 and HUVEC (Figure 7C). NK cells realm of adhesion molecules. For example, L-selectin
binds to the carbohydrate determinants exposed on theadhered to ECV304 expressing fractalkine 4-fold more
than to control ECV304. The enhanced adhesion of NK mucin structure of MAdCAM-1, GlyCAM-1, or CD34 (Gi-
rard and Springer, 1995). Nevertheless, the identificationcells to ECV304-fractalkine was strongly inhibited by
soluble fractalkine. Similarly, NK cells adhered to TNFa- of the CX3CR1 has led to findings that do not support this
model. In addition, the involvement of other adhesionactivated HUVEC 4-fold more than to control HUVEC,
and the enhanced adhesion of NK cells to activated molecules seems also precluded. Several lines of evi-
dence in the present study support this view. First,HUVEC was partially but significantly inhibited by solu-
ble fractalkine. In the latter case, involvement of other CX3CR1-expressing cells efficiently adhere to purified
fractalkine immobilized onto glass slides, showing thatadhesion pathways probably accounted for adhesion
not inhibited by soluble fractalkine. Collectively, these the adhesion can occur in the absence of substrates for
other cell adhesion molecules (Figure 3). Second, theresults support the conclusion that physical interaction
of membrane-bound fractalkine and V28 is indeed capa- adhesion was robust in the absence of divalent cations,
which are required for integrin- or selectin-mediatedble of directly mediating cell adhesion independent of
signaling via the PT-sensitive G proteins or downstream adhesion (Figure 3) (Springer, 1994). We also confirmed
that 293/EBNA-1 cells do not express CD18, the essen-activation of other adhesion molecules, and that this
mode of adhesion can be demonstrated in primary hu- tial subunitof b2 integrins, and K562cells do not express
VLA-4 (data not shown). Furthermore, neutralizing mono-man cells as well as cells engineered to express recom-
binant fractalkine and V28. clonal anti-CD18, anti-LFA-1, anti-CD29, anti-CD49d,
and anti-CD44 had no inhibitory effect on the adhesion
(data not shown). Taken together, the evidence suggests
Discussion that fractalkine and CX3CR1 are molecules capable of
directly mediating cell adhesion as well as chemotaxis.
The CX3C chemokine fractalkine represents a fourth class Fractalkine and the CX3CR1 mediate the processes
of chemokine, which exhibits properties of both tradi- of chemotaxis and adhesion directly, but the machinery
tional chemokines and adhesion molecules, raising required for each activity is distinct. The migratory and
questions regarding the molecular nature of its receptor calcium mobilization functions controlled byCX3CR1 are
and how the receptor-ligand complex achieves its hy- G protein±linked and can be inhibited by PT (Figures
brid functions. We describe here the identification of 2 and 3). By contrast, adhesion occurs in all CX3CR1
the 7-TM protein encoded by the V28 orphan cDNA as transfected cell lines tested, even in those that do not
a specific, high-affinity receptor for fractalkine. Since mobilize calcium to fractalkine or in those that are not
the V28 protein represents the first receptor for a CX3C chemotactically responsive to soluble fractalkine (Figure
chemokine, we have accordingly designated it as CX3CR1. 3). Adhesion to fractalkine is also insensitive to PT (Fig-
As in the case for CC and CXC chemokine receptors, ure 3). Thus, the adhesion via fractalkine and CX3CR1
CX3CR1 is a 7-TM G protein±coupledreceptor (Combad- occurs before, and certainly appears to be independent
iere et al., 1995; Raport et al., 1995). CX3CR1 contains of, activation of integrins and chemotaxis. This, how-
several motifs conserved among the chemokine recep- ever, does not exclude the role of CX3CR1 signaling via
tor superfamily. For example, a DRY motif, which is im- the Gai class of G proteins in activation of integrins for
portant for G protein interactions and signal transduc- subsequent firm adhesion. Another notable point is that
tion, is present. We showed in the present study that the adhesion mediated by CX3CR1 and fractalkine is
calcium mobilization and cell migration responses linked dependent on temperature (Figure 3). This may suggest
to CX3CR1 were highly sensitive to PT (Figure 2), indicat- involvement of some signaling via CX3CR1 in the ob-
ing coupling to the Gai class of G proteins. These results served adhesion. It is, however, more likely that mem-
suggest that, at least in transfected cells, CX3CR1 is brane fluidity is needed for CX3CR1-expressing cells to
capable of interacting with signal transduction machin- form multiple associations with immobilized fractalkine
ery shared with other CCRs and CXCRs (Campbell et at levels sufficient for cell adhesion.
al., 1996). It may also be noteworthy that, when aligned These results prompted our molecular dissection of
phylogenetically with other chemokine receptors, CX3CR1 how the fractalkine architecture was important in the
is more closely related to CC chemokine receptors than achievement of adhesion with CX3CR1. Fractalkine is
to those for CXC chemokines. This may relate to its bio- apparently a hybrid molecule comprising the CX3C
logical specificity for T cells, NK cells, and monocytes, chemokine as an effector domain and the mucin-like
which mimic the known activities of CC chemokines stalk as a presentation structure (Bazan et al., 1997).
First, the binding of fractalkine to CX3CR1 seems to(Baggiolini et al., 1994; Rollins, 1997).
Cell
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be solely the function of the chemokine domain. The NK cells and 2.5% of CD81 T cells added to the assay
migrated (Figure 6). Thus, roughly 10% of the receptor-chemokine domain alone bound toCX3CR1 as efficiently
as the whole extracellular region of fractalkine, giving a expressing cells of each subset responded to soluble
fractalkine in our experimental conditions. Althoughsimilar high affinity and number of binding sites (Figure
4). With regard to receptor binding, the mucin domain 80% of CD141 monocytes expressed fractalkine recep-
tors (Figure 5), only 1% of input cells, that is, only 1.3%seemed to have no direct role, since the mucin domain
alone showed no binding to CX3CR1-expressing cells of the receptor-expressing cells, migrated to soluble
fractalkine (Figure 7). Furthermore, THP-1 cells, a mono-nor any positive or negative effect on the binding of the
chemokine domain to CX3CR1 (Figure 4). Collectively, cytic cell line, migrated to MCP-1 but not to soluble
fractalkine, even though they expressed fractalkine re-these results indicate that the chemokine domain is the
sole effector domain for CX3CR1, possessing a similar ceptor on the surface (data not shown). These results
suggest that the receptor expression per se does notbiological activity as other CC, CXC, or C chemokines.
What, then, is the role of the mucin-like domain? We determine migration activity of leukocytes to fractalkine.
Fractalkine is likely tobe expressed on thecell surfacedemonstrated that both the chemokine and mucin do-
mains were necessary for efficient adhesion induction of endothelial cells in inflamed tissues (Bazan et al.,
1997). This would induce adhesion of cells such as NKof CX3CR1-expressing cells (Figure 4). However, the sol-
uble mucin domain alone or the mucin domain linked cells expressing CX3CR1. To address this notion, we
examined the role of fractalkine in the adhesion ofto a CC chemokine TARC did not inhibit cell adhesion
mediated by immobilized fractalkine. Furthermore, coim- CX3CR1-expressing cells to fractalkine-expressing en-
dothelial cells. K562 cellsexpressing CX3CR1 vigorouslymobilization of the chemokine domain and the mucin
domain as separate molecules at a 1:1 ratio did not adhered to ECV304 cells expressing transfected fractal-
kine and to TNFa-stimulated HUVEC expressing endog-support the adhesion at all (Figure 4). Thus, it seems
unlikely that the mucin domain is directly involved in cell enous fractalkine (Figure 7). The enhanced adhesion of
K562 cells expressing CX3CR1 to fractalkine-expressingadhesion as an adhesion domain. Most probably, the
mucin domain functions primarily as an efficient presen- cells was almost completely blocked by soluble fractal-
kine (Figure 7), even though soluble fractalkine itself wastation molecule for the chemokine domain. This, how-
ever, does not exclude a potential role of the mucin a potent agonist for CX3CR1 in induction of chemotaxis
and calcium mobilization (Figure 3). Furthermore, PT ordomain in cell adhesion as a ligand for some lectins in
natural settings. EDTA/EGTA had little inhibitory effect on the observed
cell adhesion. Thus, the cell-to-cell adhesion promotedIn the case of other CC, CXC, or C chemokines, they
have to be retained and presented by surface molecules by CX3CR1 and membrane-bound fractalkine was also
mostly independent of signaling via PT-sensitive G pro-on endothelial cells, otherwise they are rapidly diluted
by blood flow (for review, see Schall and Bacon, 1994). teins or divalent cation-dependent integrins and selec-
tins, and thus probably mediated by direct physical as-The heparin-binding property of these chemokines may
provide a mechanism for retention in the extracellular sociation of fractalkine and CX3CR1. Similarly, freshly
isolated NK cells expressing endogenous CX3CR1 (Fig-matrix or by cell-bound proteoglycan so as to be pre-
sented on the endothelial cells for rolling lymphocytes. ure 5) adhered well toECV304 cellsexpressing transfected
fractalkine and also to TNFa-treated primary HUVECFractalkine, possessing intrinsically both the chemokine
and presentation domains, may represent a parsimoni- expressing endogenous fractalkine (Figure 7). The adhe-
sion of NK cells to these types of cells was also effec-ous solution to the presentation problem. Consistent
with this idea, even a CC chemokine, TARC, if linked to tively blocked by soluble fractalkine (Figure 7). Collec-
tively, the membrane form of fractalkine expressed onthe mucin domain of fractalkine, was capable of induc-
ing efficient adhesion of cells expressing its cognate activated endothelial cells indeed induced adhesion of
CX3CR1-expressing cells such as NK cells. The precisereceptor, CCR4 (Imai et al., 1997) (Figure 4). This obser-
vation suggests that other chemokine receptors also role of fractalkine in interaction of CX3CR1-expressing
cells and activated endothelial cells, however, requireshave a potential to support adhesion as CX3CR1 if che-
mokines are presented in a structure similar to fractal- further analysis in more physiological flow conditions.
In summary, the identification of CX3CR1 illuminateskine. This may lead to a hypothesis that chemokines and
their receptors, if the former are presented on molecules unique features in the molecular control of leukocyte
such as proteoglycans, are capable of directly mediating trafficking. At the critical interface between leukocyte
adhesion of leukocytes as well as signaling for down- cell surface and endothelium, fractalkine and CX3CR1
stream activation of integrins during the multistep process seem to blend adhesion and chemotactic properties at
of leukocyte trafficking (Butcher, 1991; Springer, 1994; the molecular and functional levels. Aside from enhanc-
Butcher and Picker, 1996). ing the basic understanding of leukocyte migration,
We demonstrated that soluble fractalkine induces mi- these molecules may also define new targets for devel-
gration of certain types of leukocytes through endothe- opment of antiinflammatory agents.
lial cells in a transendothelial migration assay. In accor-
dance with the expression of CX3CR1 mRNA and surface
Experimental Proceduresfractalkine receptor (Figure 5), CD161 NK cells and
CD31CD81 T cells efficiently migrated toward soluble Cells
fractalkine (Figure 6). Approximately 92% of CD161 NK Cells stably expressing CCR1, CCR2B, CCR3, CCR4, CCR5, CCR6,
cells and 25% of CD31CD81 T cells express fractalkine CCR7, V28/CMKBRL1,BLR1, orGPR-9±6 (GenBank accession num-
ber: HSU45982) were described previously (Imai et al., 1997).receptor on the cell surface (Figure 5), and 8% of CD161
Identification of Fractalkine Receptor CX3CR1
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ECV304 cells were obtained from American Type Culture Collection Triton X-100, and heated at 658C for 10 min to inactivate cellular
phosphatases. Lysates were collected by centrifugation, and APand maintained in M199 medium supplemented with 10% FBS. For
stable expression of membrane-bound fractalkine in ECV304 cells, activity in 10 ml of lysate was determined by the chemiluminescent
assay. All assays were done in duplicate. Binding data were ana-the expression plasmid pCAGG-Neo-fractalkine-1 was transfected
into ECV304 by Lipofectamine (GIBCO-BRL). After selection with lyzed by the LIGAND program.
800 mg/ml of G418 for 1±2 weeks, drug-resistant cells were pooled
and incubated with an anti-fractalkine MAb (T. I. et al., unpublished
Chemotaxis and Calcium Mobilization Assaysdata). After washing, cells were stained with FITC-conjugated anti-
Cell migration assay in a 48-well microchemotaxis chamber andmouse IgG, and cells expressing membrane-bound fractalkine were
across a polyvinylpyrrolidone-free polycarbonate filter (8 mm pores)obtained by sorting on a FACStar Plus. Peripheral blood mononu-
precoated with type IV collagen was carried out as described pre-clear cells (PBMC) and granulocytes were isolated from venous
viously (Imai et al., 1997). Each sample was assayed in triplicate,blood obtained from healthy adult donors as described previously
and migrated cells were counted in five randomly selected high-(Imai et al., 1997). Further fractionation of lymphocytes into classes
power fields (3400) per well.Calcium mobilization assay was carriedand subsets was also carried out as described previously (Imai et
out as described previously (Imai et al., 1997). Transendothelial che-al., 1997). The purity of each cell population was in the range of
motaxis assay was carried out by using an endothelial cell line95%±99% as determined by flow cytometric analysis.
ECV304 as described previously (Carr et al., 1994; Oin et al., 1996).
In brief, ECV304 cells (2 3 105) were added on Transwell cultureProduction of Recombinant Proteins
inserts (Coaster) with a 5 mm pore size and cultured at 378C for 48±96To express Fractalkine-SEAP, the DNA fragment encoding fractal-
hr in M199 medium supplemented with 10% FBS. Chemokines werekine was amplified from fractalkine cDNA by PCR using 59 SalI-
diluted in migration medium (RPMI-1640:M19951:1, 0.5% BSA) andfractalkine primer (159-CGCGTCGACTCAGCCATGGCTCCGATA
added to 24-well tissue culture plates in a final volume of 600 ml.TCT-39) and 39 fractalkine-XbaI primer (259-CGCTCTAGAGGTGGC
Endothelial cell±coated inserts were placed in each well, and 106AGCCTGGGCGTCAGG-39) and subcloned into pDREF-SEAP(His)6-
PBMC in 100 ml were added to the upper chamber. The cells wereHyg vector as described previously (Imai et al., 1997). CX3C-SEAP
allowed to migrate through endothelial cells to the lower chamberwas similarly generated using 59 SalI-fractalkine primer (see above)
at 378C for 4 hr. The cell suspensions from the lower chamber wereand 39 fractalkine-XbaI-2 primer (259-CGCTCTAGATAGGGCAGCA
then stained with FITC or PE-conjugated MAb to CD3, CD4, CD8,GCCTGGCGGTC-39). For generation of Mucin-SEAP, the DNA frag-
CD14, CD16, or CD19. The migrated cells were then counted usingment encoding SalI-oncostatin M signal sequence-XbaI-fractalkine
flow cytometry.lacking the chemokine domain NheI was amplified by three-step
PCR using 59 SalI-OMC-XbaI-fractalkine primer (159-CTGTTTCCA
AGCATGGCGAGCATGTCTAGAAATGGCGGCACCTTCGAGAAG-39)
Adhesion Assayand 39 fractalkine-NheI primer (259-CGCGCTAGCGGTGGCAGCCT
Each well of 16-well glass slides was coated with 50 ml of anti-SEAPGGGCGTCAGG-39). TARC-SEAP was described previously (Imai et
antibody (10 mg/ml) in 50 mM Tris-HCl (pH 9.5) at 48C overnight.al., 1997). TARC-mucin-SEAP was generated by replacing onco-
After washing with PBS, nonspecific binding sites were blockedstatin signal sequence of Mucin-SEAP to TARC. 293/EBNA-1 cells
with adhesion buffer (RPMI-1640, 1% BSA, 20 mM HEPES [pH 7.4]).were transfected with the expression vectors for various recombi-
The SEAP fusion proteins (10 nM) were added to wells, and thenant proteins by using Lipofectamine (BRL). After 3±4 days, the
plates were incubated at room temperature for 2 hr and washedsupernatants were collected. For one-step affinity purification, su-
extensively. Cells (4000 cells/mm2) were applied to each well in finalpernatants were applied to 1 ml of Hisbond resin (Qiagen, Hilden,
volume at 50 ml and incubated for 30 min at room temperature.Germany). After washing, bound recombinant proteins were eluted
After washing off nonadherent cells by dipping the slides gently inwith 100 mM imidazol. The concentration of each recombinant pro-
adhesion buffer twice, cells were fixed with 1% glutaraldehyde. Totein was determined by a sandwich-type enzyme-linked immunosor-
assess cell adhesion to endothelial cells, control ECV304 andbent assay as described previously (Imai et al., 1997). AP activity
ECV304 transfected with the full-length fractalkine cDNA werewas determined by a chemiluminescent assay using Great Escape
added to wells precoated with polyethyleneimine at 1 3 105 cellsDetection Kit (Clontech). The enzymatic activity was expressed as
per well a day before the assay. Similarly, HUVEC were added torelative light unit (RLUs).
wells precoated with fibronectin at 2 3 104 cells per welland culturedSoluble fractalkine with a tag of six histidine residues, (His)6, at for 2 days before the assay. Some HUVEC cultures were treatedits C terminus was prepared by using a baculovirus expression
with TNFa for 10 hr prior to the assay. The purity of NK cells usedsystem. The cDNA fragment encoding the extracellular domain of
was in the range of 80%±90% as determined by flow cytometricfractalkine was subcloned into the SalI-XbaI sites of the modified
analysis. All assays were performed in duplicate, and the percentpFastBac1 baculovirus transfer vector (GIBCO-BRL) to express
adhesion of input cells was determined by counting cells in fivefractalkine as a soluble fusion protein with Ser-Arg-Ser-Ser-Gly-
4003 fields (0.07 mm2) per well.(His)6. The recombinant bacmids were generated in E. coli DH10Bac
and transfected into Spodoptera frugiperda Sf9 cells using Lipofec-
tin (GIBCO-BRL) to obtain the recombinant viruses. For expression Northern Blot and Flow Cytometric Analysis
of the recombinant fractalkine-(His)6, Trichoplusia ni BTI-TN-5B1±4 Northern blot analysis was carried out as described previously (Imai
cells were infectedwith the recombinant viruses at moi of 10±20. The et al., 1997). For flow cytometric analysis of fractalkine receptor,
culture supernatants collected 2 days after infection were applied to PBMC or granulocytes were incubated with 10 nM of Fractalkine-
a 1 ml Hisbond resin (Qiagen). After washing, boundfractalkine-(His)6 SEAP or control SEAP on ice for 30 min in staining buffer (1% FBS,
was eluted with 100 mM imidazol. Fractions containing recombinant 2.5% human AB serum, 0.02% sodium azide in PBS). After washing,
fractalkine-(His)6 were pooled and dialyzed to PBS. Protein concen- cells were incubated with biotinylated anti-SEAP antibody, washed,
trations were determined by the BCA kit (Pierce, Rockford, IL). Endo- and then incubated with FITC-conjugated streptavidin and PE-con-
toxin levels were determined by the Limulus amoebocyte lysate jugated antibody for leukocyte subset makers. Cells were then ana-
assay (QCL-1000) (Bio Whitaker, Walkersville, MD) and were ,4 pg lyzed on a FACStar Plus (Beckton Dickinson, Mountain View, CA).
per mg of recombinant fractalkine-(His)6.
Receptor Binding Assay Acknowledgments
This was carried out as described previously (Imai et al., 1997). In
brief, cells were incubated for 1 hr at 168Cwith increasing concentra- We thank Drs. Y. Himuna, M. Hatanaka, K. Takatsuki, and R. Miura
tions of SEAP-fusion proteins in the presence or absence of 200 for constant support and encouragement.
nM soluble fractalkine in 200 ml of RPMI-1640 containing 20 mM
HEPES (pH 7.4), 1% BSA, and 0.02% sodium azide.After incubation,
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